Can Proteomics Refine Lung Screening?

• by Kathryn Wighton

• June 1, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

Prognostic superiority of volumetric PET parameters (MTV and TLG) over SUV in advanced non-small-cell lung cancer: a systematic review and meta-analysis of univariate and multivariate evidence

• by Jinwen Han, Hanxiang Zhang, Xianhong He, Zhimin Wang

• August 25, 2026

Enterovirus diversity may limit treatment advances

Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.

• by Andrea Surnit

• September 8, 2026

• 4 min